This study will be conducted at elementary schools in Oslo and aims to explore multiple aspects of school absenteeism and student well-being. It has two main objectives: 1) a preventive focus specifically related to school attendance and functioning, and 2) a user perspective that includes measuring user satisfaction with the interventions used in the study. The aim is to investigate whether the EMOTION intervention can be utilized to enhance school attendance and functioning for children experiencing emerging difficulties in attending school, who also tend to be more sad and anxious than their peers. Additionally, the study seeks to compare changes in anxiety and sadness with previous studies involving the EMOTION intervention through benchmarking. The perceptions of parents regarding the causes of their children's difficulties will also be examined. Evaluating user satisfaction with the EMOTION intervention in relation to emerging school absenteeism and the implementation of attendance teams in the schools is another objective. This will contribute to increased knowledge about interventions targeting children with emerging difficulties in school attendance and their experiences with these interventions.
Age range
8 Years – 13 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Primar outcomes for absenteeism
Timeframe: From screening for enrollment (T1), at the end of treatment after approximately 10 weeks (T2) and 6 moths after the intervention finished (T3)